|
RIF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.245400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.158100E-02 |
| Normal-vs-Stage2 |
8.406600E-01 |
| Normal-vs-Stage3 |
8.230600E-01 |
| Normal-vs-Stage4 |
6.583800E-01 |
| Stage1-vs-Stage2 |
4.454200E-01 |
| Stage1-vs-Stage3 |
2.570600E-01 |
| Stage1-vs-Stage4 |
7.671800E-01 |
| Stage2-vs-Stage3 |
7.544600E-01 |
| Stage2-vs-Stage4 |
8.307400E-01 |
| Stage3-vs-Stage4 |
6.457600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.922600E-01 |
| Normal-vs-AfricanAmerican |
1.603780E-01 |
| Normal-vs-Asian |
4.508800E-01 |
| Caucasian-vs-AfricanAmerican |
4.106000E-01 |
| Caucasian-vs-Asian |
6.585200E-01 |
| AfricanAmerican-vs-Asian |
7.823400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.792370E-02 |
| Normal-vs-Female |
4.770100E-02 |
| Male-vs-Female |
8.184500E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.814000E-02 |
| Normal-vs-Extreme_Weight |
2.859300E-03 |
| Normal-vs-Obese |
4.138000E-01 |
| Normal-vs-Extreme_Obese |
4.549200E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.304800E-01 |
| Normal_Weight-vs-Obese |
2.628300E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.430000E-01 |
| Extreme_Weight-vs-Obese |
5.702500E-03 |
| Extreme_Weight-vs-Extreme_Obese |
5.550200E-01 |
| Obese-vs-Extreme_Obese |
3.786400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.243200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.071800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.418300E-03 |
| Normal-vs-Age(81-100Yrs) |
1.739730E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.054200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.431800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.164200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.537800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.256100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.337400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.535000E-01 |
| Normal-VS-Type2 PRCC |
2.466000E-02 |
| Normal-VS-KIRP CIMP |
1.316240E-01 |
| Normal-VS-Unclassified PRCC |
2.211000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.110800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.028300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.788000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.792000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.304300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.248800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.252070E-02 |
| Normal-vs-N1 |
1.995350E-01 |
| Normal-vs-N2 |
9.069000E-01 |
| N0-vs-N1 |
3.197900E-02 |
| N0-vs-N2 |
3.347000E-01 |
| N1-vs-N2 |
6.416600E-01 |
|
|
